Cross-Protective Shigella Whole-Cell Vaccine With a Truncated O-Polysaccharide Chain-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cross-Protective Shigella Whole-Cell Vaccine With a Truncated O-Polysaccharide Chain

Published:2018-10-31 Issue: Volume:9 Page:
ISSN:1664-302X
Container-title:Frontiers in Microbiology
language:
Short-container-title:Front. Microbiol.

Author:

Kim Min Jung,Moon Young-hye,Kim Heejoo,Rho Semi,Shin Young Kee,Song Manki,Walker Richard,Czerkinsky Cecil,Kim Dong Wook,Kim Jae-Ouk

Funder

PATH

Korea Health Industry Development Institute

National Research Foundation of Korea

Publisher

Frontiers Media SA

Subject

Microbiology (medical),Microbiology

Reference49 articles.

1. Progress and pitfalls in Shigella vaccine research;Barry;Nat. Rev. Gastroenterol. Hepatol,2013

2. Induction of a local anti-IpaC antibody response in mice by use of a Shigella flexneri 2a vaccine candidate: implications for use of IpaC as a protein carrier;Barzu;Infect. Immun,1996

3. The tripartite type III secreton of Shigella flexneri inserts IpaB and IpaC into host membranes;Blocker;J. Cell Biol,1999

4. Escherichia coli heat-labile enterotoxin promotes protective Th17 responses against infection by driving innate IL-1 and IL-23 production;Brereton;J. Immunol,2011

5. Recent progress towards development of a Shigella vaccine;Camacho;Expert Rev. Vaccines,2013

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shigella Vaccines: The Continuing Unmet Challenge;International Journal of Molecular Sciences;2024-04-13

2. A Perspective on the Strategy for Advancing ETVAX®, An Anti-ETEC Diarrheal Disease Vaccine, into a Field Efficacy Trial in Gambian Children: Rationale, Challenges, Lessons Learned, and Future Directions;Microorganisms;2023-12-31

3. Encapsulation: The path to commercialization of stable perovskite solar cells;Matter;2023-11

4. Characterization of Shigella flexneri Serotype 6 Strains Isolated from Bangladesh and Identification of a New Phylogenetic Cluster;Journal of Bacteriology;2023-04-25

5. Oral inactivated whole cell vaccine for mucosal immunization: ETVAX case study;Frontiers in Immunology;2023-03-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3